Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Ann Hematol
1 Blood
1 Bone Marrow Transplant
3 Haematologica
5 J Pediatr Hematol Oncol
2 J Trop Pediatr
1 Leukemia
1 N Engl J Med
1 Nephrol Dial Transplant

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Hematol

  1. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
    Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.


  2. SHENG Y, Ma R, Yu C, Wu Q, et al
    Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice.
    Blood. 2021;137:610-623.
    PubMed         Abstract available

    Bone Marrow Transplant

  3. IFTIKHAR R, Ahmad P, de Latour R, Dufour C, et al
    Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia workin
    Bone Marrow Transplant. 2021 May 19. pii: 10.1038/s41409-021-01332.
    PubMed         Abstract available


  4. STONE EF, Avecilla ST, Wuest DL, Lomas-Francis C, et al
    Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
    Haematologica. 2021;106:310-312.

  5. BLOMBERY P, Fox L, Ryland GL, Thompson ER, et al
    Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
    Haematologica. 2021;106:64-73.
    PubMed         Abstract available

  6. BRODSKY RA, Peffault de Latour R, Rottinghaus ST, Roth A, et al
    Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2021;106:230-237.
    PubMed         Abstract available

    J Pediatr Hematol Oncol

  7. AL-HUNITI A, Rathi N, Modi A, Bhagavathi S, et al
    Up-front Treatment With Romiplostim in Children With Acquired Bone Marrow Failure: A Single Institutional Pediatric Case Series.
    J Pediatr Hematol Oncol. 2021;43:e431-e435.
    PubMed         Abstract available

  8. MURTAS A, Zanza C, Vacca N, Saderi L, et al
    Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major: An Observational Study.
    J Pediatr Hematol Oncol. 2021;43:118-119.

  9. YAMSRI S, Kawon W, Duereh A, Fucharoen G, et al
    Southeast Asian Ovalocytosis and Hemoglobinopathies in Newborns: Prevalence, Molecular, and Hematologic Analyses.
    J Pediatr Hematol Oncol. 2021;43:e341-e345.
    PubMed         Abstract available

  10. NANDAKUMAL G, Ismail F, Mohamad NF, Lott PW, et al
    A Rare Case of von Willebrand Disease Presenting as Hemolacria and Literature Review.
    J Pediatr Hematol Oncol. 2021;43:101-103.
    PubMed         Abstract available

  11. KNIGHT LMJ, King AA, Strouse JJ, Tanabe P, et al
    Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.
    J Pediatr Hematol Oncol. 2021;43:104-111.
    PubMed         Abstract available

    J Trop Pediatr

  12. RAMASWAMY G, Vohra K, Yadav K, Kaur R, et al
    Point-of-Care Testing Using Invasive and Non-Invasive Hemoglobinometers: Reliable and Valid Method for Estimation of Hemoglobin among Children 6-59 Months.
    J Trop Pediatr. 2021;67.
    PubMed         Abstract available

  13. AKODUI OS, Faleti AO, Adekanmbi FA, Ogunlesi TA, et al
    Predicted Reference Equations for Spirometry Indices as a Proxy from Anthropometry Measurements of Nigerian Children with Sickle Cell Anaemia Aged 5-12 Years.
    J Trop Pediatr. 2021;67.
    PubMed         Abstract available


  14. Foreign Letters: London.
    JAMA. 2021;325:1907.


  15. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    PubMed         Abstract available

    N Engl J Med

  16. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.

    Nephrol Dial Transplant

  17. GOTTA V, Tancev G, Marsenic O, Vogt JE, et al
    Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.
    Nephrol Dial Transplant. 2021;36:519-528.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.